AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 93 filers reported holding AVROBIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,687,000 | -19.3% | 121,018 | -24.7% | 0.43% | -22.0% |
| Q3 2020 | $2,091,000 | -37.1% | 160,624 | -15.7% | 0.55% | -40.9% |
| Q2 2020 | $3,326,000 | -27.7% | 190,593 | -35.5% | 0.94% | -56.0% |
| Q1 2020 | $4,599,000 | +153.8% | 295,593 | +228.4% | 2.13% | +307.5% |
| Q4 2019 | $1,812,000 | – | 90,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |